Rates of phototherapy among ABO-incompatible newborns with a negative direct antiglobulin test

OBJECTIVE: We analyze phototherapy rates after implementation of a Hyperbilirubinemia Clinical Pathway (HCP), which placed full-term ABOi DAT negative newborns on the low risk phototherapy nomogram, rather than medium risk, as previously done. STUDY DESIGN: A chart review was performed for ABOi newb...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabbay, Jonathan M., Agneta, Elizabeth M., Turkington, Simon, Bajaj, Benjamin M., Sinha, Bharati, Geha, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034253/
https://www.ncbi.nlm.nih.gov/pubmed/36959468
http://dx.doi.org/10.1038/s41372-023-01650-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034253/
https://www.ncbi.nlm.nih.gov/pubmed/36959468
http://dx.doi.org/10.1038/s41372-023-01650-3

Ejemplares similares